Poncirin
Based on 4 publication(s) in Google Scholar
Poncirin is isolated from Poncirus trifoliata with anti-inflammory activites. Poncirin significantly reduces mechanical hyperalgesia and allodynia in Complete Freund’s Adjuvant (CFA)-induced inflammatory pain models.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.98%
- CAS No.: 14941-08-3
- Formule: C28H34O14
- Masse moléculaire:594.56
-
Stockage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-15337
HesperidinAntioxidant -
HY-N2068
DidyminApoptosis Inducer -
HY-N0297
SinensetinTNF Receptor Inhibitor -
HY-N0171A
Beta-Sitosterol (purity>98%)Dietary Plant Sterols -
HY-N0178
DiosminAryl Hydrocarbon Receptor Agonist -
HY-N0755
RhoifolinFlavone Glycoside -
HY-N0101
NeohesperidinWnt/β-Catenin Activator -
HY-N2258R
Poncirin (Standard)Anti-Hyperalgesia Agent -
HY-N0528
LinarinAChE Inhibitor -
HY-N0528R
Linarin (Standard)AChE Inhibitor
Publications Citing Use of MedChemExpress (MCE) Poncirin
More
Customer Validation & Images
-
Cell Proliferation/Viability Assay
-
Flow Cytometry
-
WB
-
In Vivo Efficacy Study
-
Histological Imaging/Staining
Activité biologique
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 14941-08-3
-
Appearance Solid
-
Masse moléculaire 594.56
-
Formule C28H34O14
-
Color White to off-white
-
SMILES
O=C(C[C@@H](C1=CC=C(OC)C=C1)OC2=CC(O[C@H](O[C@H](CO)[C@@H](O)[C@@H]3O)[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]4O)([H])[C@@H]4O)=C5)C2=C5O
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
Food Chem
Effects of sun drying combined with baking processes on the flavor quality of Chongqing Tuocha raw tea. [Abstract]2025 Dec 30:497:146992. PMID: 41285060 -
Food Chem
Flavonoid-mediated metabolic underpinning quality variation in red bud-sport pear mutants. [Abstract]2025 Oct 15:489:144992. PMID: 40466530 -
Eur J Pharmacol
Poncirin ameliorates cardiac ischemia-reperfusion injury by activating PI3K/AKT/PGC-1α signaling. [Abstract]2022 Feb 15:917:174759. PMID: 35032487
Poncirin purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2022 Feb 15:917:174759. [Abstract]
Effect of different concentrations of Poncirin (Pon) (12.5, 25, 50, 100, 150 μM) pretreatment on cell viabilities after A/R.
Poncirin purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2022 Feb 15:917:174759. [Abstract]
Poncirin (Pon) (50 μM) pretreatment reduced peak ROS accumulation induced by A/R as measured by DCF staining and flow cytometry.
Poncirin purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2022 Feb 15:917:174759. [Abstract]
Representative Western blot image and graph showing quantification of cleaved caspase 3 treated with Poncirin (Pon) (50 μM).
Poncirin purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2022 Feb 15:917:174759. [Abstract]
Myocardial infarction size was determined by TTC staining treated with Poncirin (Pon) (30 mg/kg).
Poncirin purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2022 Feb 15:917:174759. [Abstract]
Poncirin (30 mg/kg) preserved myocardial structure and prevents inflammation induced by I/R in rats.
-
Plants
Determination of Flavonoid Glycoside Isomers Using Vision Transformer and Tandem Mass Spectrometry. [Abstract]2024 Dec 4;13(23):3401. PMID: 39683194
Solvant et solubilité
In Vitro:
DMSO : 100 mg/mL (168.19 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.20 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.20 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocole
-
Formalin-Induced Paw Inflammation/Nociceptive Inflammation
The formalin-induced paw inflammation/nociceptive test is a chemical persistent pain model in rodents in which subcutaneous injection of formalin into the hind paw produces spontaneous nocifensive behaviors such as flinching and licking. The response is classically biphasic, consisting of an early acute phase (Phase I) reflecting direct activation of peripheral nociceptors (particularly C-fiber afferents), followed by a later prolonged phase (Phase II) associated with central sensitization in the spinal dorsal horn driven by sustained afferent input and inflammatory signaling. This model is widely used to evaluate analgesic and anti-inflammatory interventions because it captures both peripheral nociception and central sensitization processes within a single assay system.
Pureté et documentation
-
Fiche technique (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.6819 mL | 8.4096 mL | 16.8192 mL | 42.0479 mL |
| 5 mM | 0.3364 mL | 1.6819 mL | 3.3638 mL | 8.4096 mL | |
| 10 mM | 0.1682 mL | 0.8410 mL | 1.6819 mL | 4.2048 mL | |
| 15 mM | 0.1121 mL | 0.5606 mL | 1.1213 mL | 2.8032 mL | |
| 20 mM | 0.0841 mL | 0.4205 mL | 0.8410 mL | 2.1024 mL | |
| 25 mM | 0.0673 mL | 0.3364 mL | 0.6728 mL | 1.6819 mL | |
| 30 mM | 0.0561 mL | 0.2803 mL | 0.5606 mL | 1.4016 mL | |
| 40 mM | 0.0420 mL | 0.2102 mL | 0.4205 mL | 1.0512 mL | |
| 50 mM | 0.0336 mL | 0.1682 mL | 0.3364 mL | 0.8410 mL | |
| 60 mM | 0.0280 mL | 0.1402 mL | 0.2803 mL | 0.7008 mL | |
| 80 mM | 0.0210 mL | 0.1051 mL | 0.2102 mL | 0.5256 mL | |
| 100 mM | 0.0168 mL | 0.0841 mL | 0.1682 mL | 0.4205 mL |
Poncirin Related Classifications
HY-N2258 Related Classifications
Powered by Bioz